News
Oncologists at AUA 2025 share promising data, including sasanlimab, cretostimogene grenadenorepvec, and TAR-200 in NMIBC.
22h
TipRanks on MSNJPMorgan biotech/Euro pharma analysts hold analyst/industry conference callMid Cap Biotechnology Analyst Joseph and European Pharmaceuticals Analyst Gordon, along with Dr. Hogarth, Prof of Medicine in Pulmonary & Critical ...
The National Security Commission on Emerging Biotechnology (NSCEB) announced on April 8, 2025, the availability of its final ...
In recent years, cell therapies have developed alongside chemotherapy and immunotherapy to become a new pillar in the treatment of patients with blood and lymph gland cancer. In solid tumors, such as ...
Genomics company, Integrated DNA Technologies, is rewriting the future of genomics, pioneering new innovations in a bold move ...
Developments in genomics are enabling the rise of personalised medicine, with therapies tailored specifically for individuals ...
The "Laboratory Supplies Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F" report has been added to ResearchAndMarkets.com's offering.The Global Laboratory Supplies ...
The expansion is a good signal for an industry that slowed down, both in Chicago and nationwide, as interest rates rose and ...
Researchers in the field of exposomics explain how cutting-edge technologies are unlocking this biological archive, ushering in a new era of disease prevention and personalized medicine.
UT researchers have created an alternative to Edman degradation for protein sequencing using bases instead of acid ...
Scientists can build microfluidic systems in a Petri dish out of collagen, cells, and other proteins with structural ...
Press Release Grove Biopharma, a private biotechnology company pioneering its Bionic Biologicsâ„¢ platform to develop therapies targeting previously intractable intracellular disease targets, today ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results